Cancer DiscovJClub
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-Driven Alveolar Rhabdomyosarcoma.
Cancer Discovery · · Journal Article · Open access
Zhang, Engel + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
CDK8 inhibition releases the muscle differentiation block in fusion-driven alveolar rhabdomyosarcoma, impairing tumor growth and inducing myogenic differentiation in vitro and in vivo.
- Why it matters: aRMS has poor survival and limited options, and the work seeks actionable vulnerabilities linked to fusion-driven biology.
- What they did: Using complex-based analysis of DepMap functional genomic data, CDK8 was identified as a dependency; CDK8 knockout and pharmacologic inhibition were then tested, alongside a genome-scale CRISPR-Cas9 drug modifier screen.
- The result: Maximal anti-tumor activity required the Mediator kinase module (including CDK8) and transcriptional cooperation with SAGA, and SIX4 mediated CDK8 inhibitor–induced activation of myogenic differentiation genes and reduced tumor proliferation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
- Open access